所罗门技术胎儿镜激光手术治疗双胎输血综合征的基于分期的受血儿与供血儿结局
单中心研究纳入402例接受所罗门技术激光手术的双胎输血综合征妊娠,按Quintero分期分析双胎出院时存活情况。总体双胎存活303例(75.4%),各期双胎存活率无显著差异(P=0.062);III期供血儿存活率低于受血儿(69.8% vs 85.8%,P<0.0001)。双胎间体重不一致>30%和脐动脉舒张末期血流缺失或反向与供血儿死亡相关。
要点
- 所罗门技术激光术后双胎存活率为75.4%(303/402),各Quintero分期双胎存活率无显著差异(P=0.062)。
- III期病例供血儿存活率低于受血儿(69.8% vs 85.8%,χ²=26.076,P<0.0001)。
- 双胎间体重不一致>30%和脐动脉舒张末期血流缺失或反向与供血儿死亡相关(P<0.001)。
核心结论
- 所罗门技术激光手术可使高比例的双胎输血综合征病例获得TTTS缓解和双胎存活。
- 除非存在显著的双胎间体重不一致和胎盘功能障碍,受血儿与供血儿存活率相当。
- 这种程度的不均等胎盘份额(通常见于III期TTTS)是导致双胎存活受阻的主要因素,原因是供血儿死亡率较高。
研究设计与样本
- 单中心研究,地点为约翰霍普金斯胎儿治疗中心,连续纳入接受所罗门技术激光手术治疗的双胎输血综合征双胎妊娠队列,共402例。
主要发现
- 402例中Quintero I期80例(19.9%)、II期126例(31.3%)、III期169例(42.0%)、IV期27例(6.7%)。
- 激光术后双胎贫血-红细胞增多序列征或复发性TTTS发生19例(4.7%),11例(2.7%)需再次激光手术。
- 未足月胎膜早破发生150例(37.3%),分娩中位孕周为32+1周。
- 双胎出院时均存活303例(75.4%):I期67/80(83.8%)、II期101/126(80.2%)、III期113/169(66.9%)、IV期22/27(81.5%)(P=0.062)。
- III期TTTS中供血儿存活低于受血儿:118/169(69.8%)vs 145/169(85.8%)(χ²=26.076,P<0.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate twin survival stratified by Quintero stage in patients with twin-to-twin transfusion syndrome (TTTS) after Solomon laser treatment. METHODS: This was a single-center study at Johns Hopkins Center for Fetal Therapy, investigating a cohort of consecutive twin pregnancies treated with the Solomon laser technique for TTTS. Preoperative Quintero stage, perioperative characteristics and obstetric factors were investigated in relation to neonatal survival of the recipient and donor twins at discharge. Determinants of twin survival were evaluated using univariate logistic regression and cumulative survival probability analyses. RESULTS: Of 402 pregnancies with TTTS that underwent Solomon laser treatment, 80 (19.9%) were diagnosed with Quintero Stage-I TTTS, 126 (31.3%) with Stage II, 169 (42.0%) with Stage III and 27 (6.7%) with Stage IV. Post-laser twin anemia polycythemia sequence or recurrent TTTS occurred in 19 (4.7%) patients and 11 (2.7%) required repeat laser surgery. Preterm prelabor rupture of membranes occurred in 150 (37.3%) patients and median gestational age at delivery was 32 + 1 weeks. In 303 (75.4%) patients, both twins were alive at discharge; 67/80 (83.8%) were Stage I, 101/126 (80.2%) were Stage II, 113/169 (66.9%) were Stage III and 22/27 (81.5%) were Stage IV (P = 0.062). Donor twin survival was lower than that of recipients in cases with Stage-III TTTS (118/169 (69.8%) vs 145/169 (85.8%) (χ2 = 26.076, P < 0.0001)). Higher intertwin size discordance and absent or reversed umbilical artery (UA) end-diastolic velocity (EDV) were associated with donor demise (Nagelkerke R2, 0.38; P < 0.001). Overall, spontaneous post-laser donor demise occurred in 53 (39.6%) patients, accounting for the majority of all losses. Cumulative donor survival decreased from 92% to 65% when intertwin size discordance was >30% and to 48% when UA-EDV was absent or reversed (P < 0.001). CONCLUSIONS: The Solomon laser technique achieves TTTS resolution and double twin survival in a high proportion of cases. Recipient and donor survival is comparable unless there is significant intertwin size discordance and placental dysfunction. This degree of unequal placental sharing, typically found in Stage-III TTTS, is the primary factor preventing double survival due to a higher rate of donor demise. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Kyvernitakis I, Rosner M, Birk A, et al. Stage-based recipient and donor outcome in twin-to-twin transfusion syndrome treated by fetoscopic laser surgery using Solomon technique. Ultrasound Obstet Gynecol. 2024. PMID: 38379440. doi:10.1002/uog.27620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。